Dear reader,
This issue of Human Vaccines & Immunotherapeutics starts with the Immunotherapy section, which presents a review summarizing the effect of combined checkpoint blockade and radiotherapy on the tumor microenvironment (Chen, p 1555), a report on codon-optimized Listeria-based therapeutic HPV vaccine (Duan, p 1568), a mini-review of vaccinia-based vectors for use as vaccines and cancer immunotherapeutics (Zhang, p 1578), a product review of the anti-TNF MAb golimumab (Melo, p 1586), a case report on anaphylaxis following venom immunotherapy in an indolent systemic mastocytosis patient (Selcuk, p 1599), and a Letter to the Editor on memory of the innate immune system (Palmieri, p 1604).
Eight articles on Coronavirus include three surveys of parents’ willingness to enroll their children in Covid-19 vaccine trials (Goldman, p 1607), intentions to vaccinate in UK (Sherman, p 1612), and willingness to accept and pay for a vaccine in China (Zhang, p 1622), a report on pneumococcal carriage in children with Covid-19 (Aykac, p 1628), a review of vaccine development (Vashishtha, p 1635), a mini-review on disease protection by nonspecific effects of other vaccines (Mosaddeghi, p 1650), a commentary on the public discourse on vaccine roll-out and potential impact on trust and acceptance (Limaye, p 1662), and a Letter to the Editor on potential exacerbation of the next pandemic wave by vaccine hesitancy (Sticchi, p 1664).
The Acceptance segment features an analysis of vaccine compliance among preterm and low-birth-weight infants in Israel (Bary-Weisberg, p 1666), assessment of changes in parental vaccine attitudes following elimination of non-medical exemptions from school-entry requirements (Holroyd, p 1675), surveys of knowledge and practices regarding maternal pertussis vaccination among Italian gynecologists (Mazzilli, p 1681), intentions to receive pertussis vaccine among the Chinese (Tang, p 1686) and views of Turkish family physicians on vaccine rejection (Erdoğan, p 1693), a commentary on acceptance of varicella vaccine (Horváth, p 1699), and a study of the effect of message framing on vaccine uptake (Sato, p 1703).
The section on Licensed Vaccines introduces three reviews of herpes zoster incidence (Van Oorschot, p 1714), pertussis epidemiology in Latin America (Nunes, p 1733), and burden of pertussis in South Korea (Mungall, p 1747), study of age effects on diphtheria-tetanus-pertussis antibodies (Liu, p 1757), analysis of genetic correlates of risk of fever following measles vaccination in children (Klein, p 1763), immunogenicity and safety trial of the hexavalent DTP vaccine in HIV-exposed infants in South Africa (Koen, p 1770), assessment of a rubella testing and vaccination campaign following a nationwide outbreak in Japan (Takeshita, p 1779), and a book review of Vaccines and Immunizations by Chuanxi Fu (Pei, p 1785).
Three articles on Rotavirus include a review of vaccine under-performance in LMICs (Lee, p 1787), a study of genetic susceptibility to disease among Chinese children (Wang, p 1803), and a review of strain epidemiology in China (Li, p 1811).
Two Hepatitis B articles investigate factors associated with household transmission in Beijing (Zhao, p 1818) and cost-effectiveness of universal vaccination in Iran (Mokhtari, p 1825).
The Pneumococcal section reports on the impact of PCV in Finland (Rinta-Kokko, p 1834) and preventive effects of pneumococcal and influenza vaccines in the elderly (Rose, p 1844).
Finally, we are happy to present studies of the effects of maternal Influenza vaccination on hospitalizations in children under 1 year of age (San Román Montero, p 1853), risk factors of invasive Meningococcal disease (Taha, p 1858), effectiveness of Passive Immunization in preventing RSV disease in high-risk children (Viguria, p 1867), and a commentary on Public Health lessons from vaccination experience in the Philippines (Reyes, p 1873).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss, PhD
Acquisitions Editor